Capy

FDA update

Compounded GLP-1 Products in 2026: What the FDA Says

Compounded semaglutide or tirzepatide is not the same regulatory category as an FDA-approved product. That distinction matters when reading labels and maintaining an accurate history.

Updated: 5 minCapy Editorial Teamen-US

FDA-approved and compounded do not mean the same thing

FDA-approved medicines undergo the agency's review for safety, effectiveness, and quality. Compounded drugs are not FDA approved. The FDA states that compounded medicines can serve a patient need in specific circumstances, but they should not be treated as direct equivalents merely because a familiar active-ingredient name appears on a label.

The legal framework also changes when an FDA-approved product is no longer in shortage. In April 2026, the FDA reiterated conditions that compounders must meet and explained when a compounded product may be considered essentially a copy of a commercially available drug.

The FDA concerns relevant to a personal record

The FDA has reported adverse events associated with compounded semaglutide and tirzepatide and has described errors involving measurement, calculations, strength expressions, and administration. It has also warned about salt forms whose chemical and pharmacologic properties have not been established as the same as the active ingredient in approved products.

A tracker cannot validate a compound, verify its ingredients, or determine whether a formulation is lawful or appropriate. An estimated level graph also cannot detect a preparation or measurement error.

  • Copy the dispensing label exactly
  • Keep the product or pharmacy-provided name attached to the original record
  • Do not convert units or concentrations inside a general educational article
  • Direct product-specific questions to the prescriber or dispensing pharmacist

How to read changing 2026 information

Regulatory notices, shortage status, and enforcement policies can change. Check the publication and update date on the FDA page rather than relying on an undated social post or an article that predicts future availability.

This page summarizes public FDA information and does not assess an individual product, pharmacy, prescription, or treatment decision.

Independent app disclosure

Capy is independent and is not affiliated with, sponsored by, or endorsed by the FDA, a compounding pharmacy, or any pharmaceutical manufacturer. Product names and trademarks belong to their respective owners.

Questions people ask

Questions people ask

Does compounded mean FDA approved?

No. The FDA states that compounded drugs are not FDA approved, even when they use the name of an ingredient found in an approved medicine.

Can Capy check whether my compounded product is legitimate?

No. Capy cannot authenticate a product, test its contents, verify a pharmacy, or confirm regulatory compliance.

Can an estimated medication level reveal a dosing error?

No. The estimate is based only on the records entered and is not a clinical measurement or safety system.

Primary sources

  1. FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight LossU.S. Food and Drug Administration
  2. FDA clarifies policies for compounders as national GLP-1 supply begins to stabilizeU.S. Food and Drug Administration
  3. Compounding Risk AlertsU.S. Food and Drug Administration